Acotec Scientific Holdings Limited announced that Mr. Chen CHEN (Mr. Chen) has resigned as a non-executive Director, a member of the audit committee of the Company (the Audit Committee) and an authorized representative of the Company (the Authorized Representative(s)) under Rule 3.05 of The Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the Stock Exchange) (the Listing Rules); and Mr. Ke TANG (Mr. Tang) has resigned as a non-executive Director. Each of Mr. Chen and Mr. Tang has confirmed that he has no disagreements with the Board and there are no other matters in relation to his resignation that need to be brought to the attention of the shareholders of the Company or to the attention of the Stock Exchange. The Board announced that each of Mr. Arthur Crosswell BUTCHER (Mr. Butcher) and Ms. June CHANG (Ms. Chang) has been appointed as a non-executive Director of the Company and Ms. Chang has been appointed as a member of the Audit Committee with effect from February 9, 2023.

The Audit Committee comprises two independent non executive Directors, namely Ms. Kin Yee POON and Dr. Yuqi WANG and one non-executive Director, namely Ms. Chang, with effect from February 9, 2023. Mr. Arthur Crosswell BUTCHER, aged 52, obtained a Bachelor of Arts degree in International Relations from the University of Pennsylvania in May 1992 and a Master's degree in Business Administration from Columbia University in October 2003, and has been the executive vice president and group president of the Medical Surgical business and Asia Pacific region of Boston Scientific Corporation (BSC), the controlling shareholder of the Company, since May 2022. Mr. Butcher has over 26 years of experience in the medical device industry.

Since joining Boston Scientific in December 1996 as sales representative of the Urology & Women's Health division until December 1999, Mr. Butcher has held different management roles, including executive vice president and president of the Asia Pacific region from March 2020 to April 2022, senior vice president and president of the Endoscopy division from July 2016 to February 2020, vice president and general manager of the Endoscopy division in Japan from August 2014 to June 2016, vice president of global marketing of the Endoscopy division from April 2011 to August 2014, vice president of new business development and strategic planning of the Urology & Women's Health division from September 2009 to April 2011, director of marketing and new business development of the Urology & Women's Health division from March 2008 to September 2009, director of business development and strategic planning of the Urology & Women's Health division from January 2006 to March 2008, group marketing manager of the Endourology division from April 2003 to December 2005, principal product manager of the Endourology division from April 2002 to April 2003, and regional sales manager of the Urology & Women's Health division from December 1999 to April 2002. Ms. June CHANG, aged 52, obtained of Bachelor of Arts degree from the Business School of the University of Washington in June 1997 and a Master's degree in International Management from the Thunderbird, The American Graduate School of International Management in May 2001, and is currently the president of the Greater China region of BSC since March 2020. Ms. Chang is also a member of the Chartered Institute of Management Accountants.

Ms. Chang has over 25 years of experience in holding financial and commercial leadership roles in the aerospace, automotive, consumer product and device sectors across North America, Asia Pacific region and the Greater China region. Ms. Chang joined BSC in China in October 2013 as the chief financial officer until March 2015. Ms. Chang has held different management roles in BSC, including the chief finance officer of the Greater China region from April 2015 to August 2016, chief financial officer and senior director of strategic planning, DRM & emerging markets of China from September 2016 to March 2018, vice president of finance of the Greater China region and strategic planning/IAS/DRM & emerging markets of China from April 2018 to May 2018, and vice president and managing director of the Greater China region from June 2018 to February 2020.

Prior to joining BSC, Ms. Chang was the group controller of foods and beverages of the Greater China region of PepsiCo from June 2012 to October 2013, and the head of financial planning and analysis of the Greater China region of PepsiCo from July 2008 to June 2012. Ms. Chang was also the category finance leader of the Asia, Middle East and Africa regions of Unilever from July 2001 to June 2008. Ms. Chang was a tax associate of Arthur Andersen & Co.

from September 1997 to January 2000. The Board announced that Mr. Chen has ceased to act as one of the Authorized Representatives with effect from February 9, 2023, and Ms. Jing LI has been appointed as the one of Authorized Representatives in place of Mr. Chen with effect from February 9, 2023.